Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long Non-Coding RNA CASC2 Improves Diabetic Nephropathy by Inhibiting JNK Pathway
Hui‐Hui Yang, Quan e Kan, Yong Su, et al.
Experimental and Clinical Endocrinology & Diabetes (2018) Vol. 127, Iss. 08, pp. 533-537
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

lncRNA Biomarkers of Glioblastoma Multiforme
Markéta Pokorná, Marie Černá, Stergios Boussios, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 932-932
Open Access | Times Cited: 22
The Impact of lncRNAs in Diabetes Mellitus: A Systematic Review and In Silico Analyses
Cristine Dieter, Natália Emerim Lemos, Nathalia Rodrigues de Faria Corrêa, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 57
Non-Coding RNA and Diabetic Kidney Disease
Huiwen Ren, Qiuyue Wang
DNA and Cell Biology (2021) Vol. 40, Iss. 4, pp. 553-567
Closed Access | Times Cited: 46
Roles of Identified Long Noncoding RNA in Diabetic Nephropathy
Yan Li, Keyang Xu, Kechen Xu, et al.
Journal of Diabetes Research (2019) Vol. 2019, pp. 1-8
Open Access | Times Cited: 46
Interactions Among Non-Coding RNAs in Diabetic Nephropathy
Tamil Selvi Loganathan, Siti Aishah Sulaiman, Nor Azian Abdul Murad, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 44
Regulation of Oxidative Stress by Long Non-Coding RNAs in Vascular Complications of Diabetes
Pei‐Ming Chu, Cheng‐Chia Yu, Kun‐Ling Tsai, et al.
Life (2022) Vol. 12, Iss. 2, pp. 274-274
Open Access | Times Cited: 26
Arbutin protects HK-2 cells against high glucose-induced apoptosis and autophagy by up-regulating microRNA-27a
Lina Lv, Jing Zhang, Tian Fengqun, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 2940-2947
Open Access | Times Cited: 42
Long non-coding RNAs: The hidden players in diabetes mellitus-related complications
Rasha M. Hussein
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 10, pp. 102872-102872
Closed Access | Times Cited: 13
Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease
Swayam Prakash Srivastava, Julie E. Goodwin, Pratima Tripathi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6027-6027
Open Access | Times Cited: 25
Long Noncoding RNA CASC2 Facilitated Wound Healing through miRNA‐155/HIF‐1α in Diabetic Foot Ulcers
Minjie He, Liang Tu, Ruo Shu, et al.
Contrast Media & Molecular Imaging (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 18
LncRNAs and IgA nephropathy: underlying molecular pathways and clinical applications
Mina Alimohammadi, Samaneh Kahkesh, Amirhosein Abbasi, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Downregulation of lncRNA NEAT1 inhibits mouse mesangial cell proliferation, fibrosis, and inflammation but promotes apoptosis in diabetic nephropathy.
Jian Ma, Na Zhao, Likun Du, et al.
PubMed (2019) Vol. 12, Iss. 4, pp. 1174-1183
Closed Access | Times Cited: 28
The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses
Yunyun Zhao, Guanchi Yan, Jia Mi, et al.
Computational Intelligence and Neuroscience (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 15
Urinary Long Non-Coding RNA Levels as Biomarkers of Lupus Nephritis
Cheuk‐Chun Szeto, Ho So, Peter Yam‐Kau Poon, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11813-11813
Open Access | Times Cited: 9
EDA2R mediates podocyte injury in high glucose milieu
Xiqian Lan, Vinod Kumar, Alok Jha, et al.
Biochimie (2020) Vol. 174, pp. 74-83
Open Access | Times Cited: 23
Long non‑coding RNA CASC2 ameliorates sepsis‑induced acute kidney injury by regulating the miR‑155 and NF‑κB pathway
Min Wang, Jilou Wei, Futai Shang, et al.
International Journal of Molecular Medicine (2020)
Open Access | Times Cited: 22
A Novel MIR503HG/miR-497-5p/CCL19 Axis Regulates High Glucose-Induced Cell Apoptosis, Inflammation, and Fibrosis in Human HK-2 Cells
Danping Zhang, Xiaoxiao Chen, Dan Zheng
Applied Biochemistry and Biotechnology (2022) Vol. 194, Iss. 5, pp. 2061-2076
Closed Access | Times Cited: 13
Long non-coding RNA cancer susceptibility candidate 2 (CASC2) alleviates the high glucose-induced injury of CIHP-1 cells via regulating miR-9-5p/PPARγ axis in diabetes nephropathy
Feng Li, Bo Dai, Xiquan Ni
Diabetology & Metabolic Syndrome (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 19
The role of programmed cell death in diabetic foot ulcers
Juncheng Li, C.X. Jiang, Jian Xia
International Wound Journal (2023) Vol. 21, Iss. 2
Open Access | Times Cited: 7
The role of long non‐coding RNAs in the development of diabetic kidney disease and the involved clinical application
Qizhuo Hou, Bin Yi
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 4
Closed Access | Times Cited: 1
Interaction between non-coding RNAs and JNK in human disorders
Soudeh Ghafouri‐Fard, Atefe Abak, Mahdi Mohaqiq, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111497-111497
Open Access | Times Cited: 6
Knockdown of transient receptor potential melastatin 2 reduces renal fibrosis and inflammation by blocking transforming growth factor-β1-activated JNK1 activation in diabetic mice
Feng Hu, Yun Yu, Feng Lü, et al.
Aging (2021) Vol. 13, Iss. 22, pp. 24605-24620
Open Access | Times Cited: 6
Network Pharmacology Approach to Investigate the Mechanism of Danggui-Shaoyao-San against Diabetic Kidney Disease
Yulian Chen, Xiaodan Song, Yunxia Luo, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 2
Personalized epigenetic management of diabetes
Divika Sapehia, Nidhi Bhardwaj, Himanshi Goyal, et al.
Elsevier eBooks (2024), pp. 363-398
Closed Access
Artemisinin ameliorates diabetic retinopathy by upregulating CASC2/miR-155/SIRT1 axis
Lingzhen Kong, Zheng Zhang
Tropical Journal of Pharmaceutical Research (2021) Vol. 20, Iss. 10, pp. 2023-2028
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top